Adoção de terapias nutricionais enteral e parenteral associada à redução da taxa de óbitos de pacientes neoplásicos

Palavras-chave: Terapia Nutricional, Neoplasias, Desnutrição, Nutrição Enteral, Nutrição Parenteral

Resumo

Modelo do estudo: Estudo descritivo transversal. Objetivo: Este estudo analisou a relação entre a adoção da nutrição enteral e parenteral adulta e o tempo de permanência médio, a taxa de óbitos e o custo das internações de pacientes neoplásicos em hospitais do Rio Grande do Sul. Método: Foram analisados os dados dissemináveis disponíveis no SIH/SUS de 2017 do Rio Grande do Sul específicos para internações realizadas sob o diagnóstico principal associado ao CID Cap. II (Neoplasmas). Os dados foram analisados por observação da média e teste de Kruskal Wallis. Resultados: Foi observada taxa de óbito significativamente inferior em pacientes neoplásicos que foram internados em UTI e que foram submetidos às terapias dietéticas enterais e/ou parenterais, em relação aos pacientes que não receberam tais suplementos, em casos de diagnóstico de neoplasias malignas no esôfago (C15), no intestino delgado (C17) e no pâncreas (C25). Já o tempo médio de permanência e valor total médio de internações de pacientes neoplásicos tendem a ser maior em pacientes que recebem terapias dietéticas enterais e/ou parenterais, possivelmente devido à gravidade do quadro clínico. Conclusão: A adoção de nutrição enteral e parenteral apresenta potencial significativo na redução da taxa de mortalidade de pacientes com câncer no sistema digestivo, principalmente dos casos mais graves que necessitam de internação em UTI.

Downloads

Não há dados estatísticos.

Referências

Somanchi M, Tao X, Mullin GE. The facilitated early enteral and dietary management effectiveness trial in hospitalized patients with malnutrition. J Parenter Enter Nutr 2011; 35: 209–216.

Waitzberg DL, Caiaffa WT, Correia MIT. Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients. Nutrition 2001; 17: 573–580.

Dark DS, Pingleton SK. Nutrition and nutritional support in critically ill patients. J Intensive Care Med 1993; 8: 16–33.

Faisy C, Llerena MC, Savalle M, et al. Early ICU energy deficit is a risk factor for Staphylococcus aureus ventilator-associated pneumonia. Chest 2011; 140: 1254–1260.

DeFrances CJ, Lucas CA, Buie VC, et al. 2006 National hospital discharge survey. Natl Health Stat Rep 2008; 5: 1–20.

Lim SL, Ong KCB, Chan YH, et al. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr 2012; 31: 345–350.

Singer P, Hiesmayr M, Biolo G, et al. Pragmatic approach to nutrition in the ICU: expert opinion regarding which calorie protein target. Clin Nutr 2014; 33: 246–251.

Braunschweig C, Gomez S, Sheean PM. Impact of Declines in Nutritional Status on Outcomes in Adult Patients Hospitalized for More Than 7 days. J Am Diet Assoc 2000; 100: 1316–1322.

Corkins MR, Guenter P, DiMaria-Ghalili RA, et al. Malnutrition diagnoses in hospitalized patients: United States, 2010. J Parenter Enter Nutr 2014; 38: 186–195.

Petros S, Horbach M, Seidel F, et al. Hypocaloric vs normocaloric nutrition in critically ill patients: a prospective randomized pilot trial. J Parenter Enter Nutr 2016; 40: 242–249.

Pichard C, Oshima T, Berger MM. Energy deficit is clinically relevant for critically ill patients: yes. Intensive Care Med 2015; 41: 335–338.

Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009; 28: 387–400.

Genton L, Dupertuis YM, Romand J-A, et al. Higher calorie prescription improves nutrient delivery during the first 5 days of enteral nutrition. Clin Nutr 2004; 23: 307–315.

Heyland DK, Dhaliwal R, Wang M, et al. The prevalence of iatrogenic underfeeding in the nutritionally ‘at-risk’critically ill patient: Results of an international, multicenter, prospective study. Clin Nutr 2015; 34: 659–666.

Oshima T, Deutz NE, Doig G, et al. Protein-energy nutrition in the ICU is the power couple: a hypothesis forming analysis. Clin Nutr 2016; 35: 968–974.

Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. The Lancet 2013; 381: 385–393.

Oshima T, Heidegger C-P, Pichard C. Supplemental parenteral nutrition is the key to prevent energy deficits in critically ill patients. Nutr Clin Pract 2016; 31: 432–437.

Evans RA, Strauss BJG. Cost and benefit of hospital, hospital-in-the-home and ambulatory care nutrition support services. Asia Pac J Clin Nutr 1998; 7: 241–244.

Gramlich L, Kichian K, Pinilla J, et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004; 20: 843–848.

WHO. Cancer, https://www.who.int/news-room/fact-sheets/detail/cancer (2019, accessed 28 May 2019).

INCA. INCA - Instituto Nacional de Câncer. INCA - Instituto Nacional de Câncer, https://www.inca.gov.br/ (2019, accessed 28 May 2019).

Philipson TJ, Snider JT, Lakdawalla DN, et al. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care 2013; 19: 121–128.

Elia M, Normand C, Laviano A, et al. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings. Clin Nutr 2016; 35: 125–137.

Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev 2013; 12: 884–897.

Bozzetti F, Braga M, Gianotti L, et al. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. The Lancet 2001; 358: 1487–1492.

Reignier J, Boisramé-Helms J, Brisard L, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). The Lancet 2018; 391: 133–143.

Chow R, Bruera E, Chiu L, et al. Enteral and parenteral nutrition in cancer patients: a systematic review and meta-analysis. Ann Palliat Med 2016; 5: 30-41–41.

Seres DS, Valcarcel M, Guillaume A. Advantages of enteral nutrition over parenteral nutrition. Ther Adv Gastroenterol 2013; 6: 157–167.

Zhao X-F, Wu N, Zhao G-Q, et al. Enteral nutrition versus parenteral nutrition after major abdominal surgery in patients with gastrointestinal cancer: a systematic review and meta-analysis. J Investig Med 2016; 64: 1061–1074.

Kreymann KG, Berger MM, Deutz NEP, et al. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 2006; 25: 210–223.

Oliveira E de V. Dieta em UTI, seu reflexo no tratamento, recuperaçäo e custo/dia do paciente internado. Aliment Nutr 1985; 6: 38–40.

Castrao DLL e, Freitas MM de, Zaban ALRS. Terapia nutricional enteral e parenteral: complicações em pacientes críticos - uma revisão de literatura. Comun Ciênc Saúde 2009; 20: 65–74.

Tamiya H, Yasunaga H, Matusi H, et al. Comparison of short-term mortality and morbidity between parenteral and enteral nutrition for adults without cancer: a propensity-matched analysis using a national inpatient database. Am J Clin Nutr 2015; 102: 1222–1228.

Publicado
2020-08-07
Como Citar
1.
Abbade EB. Adoção de terapias nutricionais enteral e parenteral associada à redução da taxa de óbitos de pacientes neoplásicos. Medicina (Ribeirao Preto Online) [Internet]. 7ago.2020 [citado 23set.2020];53(2):115-2. Available from: http://www.revistas.usp.br/rmrp/article/view/161202
Seção
Artigo Original
Bookmark and Share